Inventor
QUINN ANTHONY
US19 patents
⚠️ This page may combine multiple inventors who share the name “QUINN ANTHONY”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ALEXION PHARMA INC
8 patentsUS11400141B2Aug 2, 2022
Methods for treating lysosomal acid lipase deficiency in patients
ALEXION PHARMA INC1 citations72
US10407671B2Sep 10, 2019
Lysosomal storage disease enzymes
ALEXION PHARMA INC3 citations72
US10493135B2Dec 3, 2019
Methods of treating tissue calcification
ALEXION PHARMA INC4 citations66
US12076376B2Sep 3, 2024
Methods for treating lysosomal acid lipase deficiency in patients
ALEXION PHARMA INC0 citations62
US11560554B2Jan 24, 2023
Lysosomal storage disease enzymes
ALEXION PHARMA INC0 citations62
US10557161B2Feb 11, 2020
Recombinant human ADA2 and ADA2 fusion proteins and methods for treating ADA2 deficiencies
ALEXION PHARMA INC1 citations54
US10858638B2Dec 8, 2020
Lysosomal storage disease enzymes
ALEXION PHARMA INC0 citations51
US10413597B2Sep 17, 2019
Methods of treating Mucopolysaccharidosis IIIB (MPSIIIB)
ALEXION PHARMA INC0 citations43
QUINN ANTHONY
5 patentsUS8663631B2Mar 4, 2014
Methods for treating lysosomal acid lipase deficiency in patients
QUINN ANTHONY15 citations91
US8846603B2Sep 30, 2014
NPP1 fusion proteins
QUINN ANTHONY26 citations90
US7867144B2Jan 11, 2011
Apparatus for exercising the chest and back
QUINN ANTHONY10 citations82
USD979673SFeb 28, 2023
Exercise device
QUINN ANTHONY0 citations61
US7976442B2Jul 12, 2011
Apparatus for exercising multiple body parts
QUINN ANTHONY5 citations61
SYNAGEVA BIOPHARMA CORP
3 patentsUS10166274B2Jan 1, 2019
Methods for treating lysosomal acid lipase deficiency in patients
SYNAGEVA BIOPHARMA CORP3 citations72
US9579366B2Feb 28, 2017
Recombinant human NaGlu protein and uses thereof
SYNAGEVA BIOPHARMA CORP2 citations71
US9540621B2Jan 10, 2017
NPP1 fusion proteins
SYNAGEVA BIOPHARMA CORP4 citations71